 |
| FRIDAY 19 SEPTEMBER |
| |
Auditorium 2 |
Brightlands foyer |
Auditorium 1 |
0.10/0.11 |
2.1/2.2 |
| Time/Society |
ESVC abstracts |
ESCG abstracts
|
ESVIM
|
ESVONC |
ESVNU
|
| 07.00-08.00 |
ECVIM-CA Cardiology Examination Info Session
07.30-08.15 |
|
|
|
|
| 08.00-09.00 |
ECVIM-CA Cardiology Informal Residents Meeting
|
|
07.30-09.00
ECVIM-CA Oral Exam Demonstration for Internal Medicine Residents and Advisors
|
07.45-09.00
ECVIM-CA Oncology Exam and Credentials info session for residents and advisors
|
08.00-08.30
Yoga Session
(2.18 / 2.19)
08.00-09.00
Zoetis Breakfast Meeting
Jonathan Elliott / Richard Goldstein
New insights on CKD pathophysiology
(Room 0.4/0.5)
|
| 09.00-09.40 |
09.00-09.15
Scurtu
ESVC-O-16
09.15-09.30
Szatmári
ESVC-O-17
09.30-09.45
Szatmári
ESVC-O-18
|
09.00-09.15
Pilla
ESCG-O-1
09.15-09.30
Bouillet
ESCG-O-2
09.30-09.45
Rudinsky
ESCG-O-3
|
Dominique Paepe (BE), Sofie Marynissen (BE)
Evidence-based health screening in senior dogs and cats
|
Katrin Toerner (DE)
Molecular and genetic landscape of canine urogenital tumours: will the diagnostic paradigm change?
|
09.30-09.45
Benoit
ESVNU-O-11
|
| 09.45-10.25 |
09.45-10.00
Melis
ESVC-O-19
10.00-10.15
Rishniw
ESVC-O-20
10.15-10.30
Miralles-Plaza
ESVC-O-21
|
09.45-10.00
Barko
ESCG-O-4
10.00-10.15
Farges
ESCG-O-5
10.15-10.30
Moraiti
ESCG-O-6
10.30-10.45
Moraiti
ESCG-O-7
|
Hanneke Joosten (NL)
Evidence-based health screening in elderly – the human perspective
|
Anthony Mutsaers (CA)
Stereotactic radiosurgery and Intensity-modulated radiation for canine urogenital carcinomas: role of positioning and tumour extent assessment in the local control outcome
|
09.45-10.00
Coates
ESVNU-O-13
10.00-10.15
Cornish
ESVNU-O-14
10.15-10.30
Dreller
ESVNU-O-15
|
|
10.30-11.15
|
COFFEE BREAK - EXHIBITION
|
| 11.20-12.00 |
11.20-11.35
Apolloni
ESVC-O-22
11.35-11.50
Rishniw
ESVC-O-23
11.50-12.05
Showers
ESVC-O-24
|
11.20-11.35
Wright
ESCG-O-8
11.35-11.50
Thenard
ESCG-O-9
11.50-12.05
Halka
ESCG-O-10
|
Holger Volk (DE)
New insights into cognitive dysfunction in dogs and cats
|
Anthony Mutsaers (CA)
Is there any benefit in using tyrosine-kinase inhibitors for canine urogenital carcinomas?
|
Catherine Trumel (FR)Pitfalls in haematology: pre analytical and analytical errors
|
| 12.05-12.45 |
12.05-12.20
Patata
ESVC-O-25
12.20-12.35
Alibrandi
ESVC-O-26
12.35-12.50
Borgarelli
ESVC-O-27
|
12.05-12.20
Alonzo
ESCG-O-11
12.20-12.35
Toresson
ESCG-O-12
12.35-12.50
Montanes Sancho
ESCG-O-13
12.50-13.05
Kyriakopoulou
ESCG-O-14
|
Karelle Leroy (BE)
Neurodegenerative disorders in people and cats, what do they have in common?
|
Gerard McLauchlan (UK), Alex Horton (UK)
Intra-arterial chemotherapy and embolisation for canine urogenital cancer
|
Catherine Trumel (FR)
The hidden hints of in-clinic haematology |
|
12.50-14.20
|
LUNCH BREAK - EXHIBITION
|
| 13.20-14.15 |
ESVC AGM |
ESVIM AGM |
ESCG AGM |
Oncology Resident meeting |
Oncology Diplomate meeting
|
| Time/Society |
ESVC |
ESVIM abstracts
|
ESCG
|
Masterclass and Research Stream |
ESVONC abstracts |
| 14.25-15.05 |
Laura Marconato (IT)
Cardiac Hemangiosarcoma: Still Heart-Breaking? Exploring New Treatment Options
|
14.40-14.55
Huang
ESVIM-O-6
14.55-15.10
Rösch
ESVIM-O-7
|
Alice Defarges (CA)
Current Landscape of Wireless Capsule Endoscopy in Canine Gastroenterology: A Comparative Analysis with Human Applications
|
Adrian Boswood (UK)
How to undertake peer review of scientific manuscripts. The role of peer review in the publication process |
14.25-14.40
Maga
ESVONC-O-1
14.40-14.55
Ng
ESVONC-O-2
14.55-15.10
Fejös
ESVONC-O-3
|
| 15.10-15.50 |
Massimiliano Tursi (IT)
Gross and histological diagnosis of primary cardiac tumours in dogs and cats
|
15.10-15.25
Chang
ESVIM-O-8
15.25-15.40
Robinne
ESVIM-O-9
15.40-15.55
Lyssens
ESVIM-O-10
|
Alice Defarges (CA)
Looking ahead: When and How to Optimize Capsule Endoscopy in Canine Diagnostics
|
Adrian Boswood (UK)
How to get your article published and where to do so |
15.10-15.25
Zdyrski
ESVONC-O-4
15.25-15.40
Buisset
ESVONC-O-5
15.40-15.55
Ronel
ESVONC-O-6
|
|
15.55-16.25
|
COFFEE BREAK - EXHIBITION
|
| 16.30-17.10 |
16.30-16.45
Padrosa Sala
ESVC-O-28
16.45-17.00
Isayama
ESVC-O-29
17.00-17.15
McAulay
ESVC-O-30
|
16.30-16.45
Gareis
ESVIM-O-11
16.45-17.00
Seedat
ESVIM-O-12
17.00-17.15
Doyle
ESVIM-O-13
|
Marcus Candido (FI)
Narrow-band-imaging" (NBI) in early detection of gastric carcinoma
|
ESVE research reports
16.30-17.00 S. Golinelli
New insights into the clinical features, clinicopathological abnormalities, diagnosis, treatment, and monitoring of canine Cushing’s Syndrome
17.00-17.30 A. Tardo
Advancements in therapeutic and monitoring options for canine and feline diabetes mellitus
17.30-18.00 M. van den Berg
Canine pheochromocytoma: advances in diagnosis, molecular and metabolomic profiling, therapeutic strategies, organoid modeling, and prognostication
|
16.30-16.45
Turchi
ESVONC-O-9
16.45-17.00
Mochel
ESVONC-O-10
17.00-17.15
McCarthy
ESVONC-O-11
|
| 17.15-17.55 |
17.15-17.30
Guillot
ESVC-O-31
17.30-17.45
Frizzo-Ramos
ESVC-O-32
17.45-18.00
Malcolm
ESVC-O-33
|
17.15-17.30
Pandya
ESVIM-O-14
17.30-17.45
Pradera
ESVIM-O-15
17.45-18.00
Zdyrski
ESVIM-O-16
|
Alejandro Suárez-Bonnet (UK)
Canine gastric carcinomas: Early diagnosis, is it possible? Lessons from the human counterpart and a veterinary pathologist’s perspective
|
17.15-17.30
Zaniboni
ESVONC-O-12
17.30-17.45
Freiche
ESVONC-O-13
17.45-18.00
|
| 18.00-18.30 |
Meet the executive ECVIM-CA
|
|
|
|
|
| 19.30-01.00 |
CONGRESS EVENING AND DANCE PARTY (bus transport at 19.00)
|
